Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONICA trial of mycophenolate mofetil for neuromyelitis optica in Chinese adults
ChiCTR-OPB-16007730Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate mofetil in neuromyelitis optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Annual relapse rate. Started Jan 2016; status: recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
neuromyelitis optica (NMO)Neuromyelitis Optica Spectrum Disorder (NMOSD)
Beyond the preview
Go deeper on ChiCTR-OPB-16007730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPB-16007730.